Prosecution Insights
Last updated: April 19, 2026

Vivex Biologics Group Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
2
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18058112 SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE D' AMBROSIO, THEA 1654 Non-Final OA Nov 22, 2022
18051663 EXOSOME COMPOSITION AND METHOD OF MANUFACTURE KIM, TAEYOON 1631 Final Rejection Nov 01, 2022
17895276 UMBILICAL CORD BIOLOGIC STENT OR CONDUIT PASQUALINI, HANNA LOUISE 3774 Final Rejection Aug 25, 2022
17714378 MIXING CONTAINER AND METHOD OF USE MCCARTY, PATRICK M 1774 Non-Final OA Apr 06, 2022
15898558 COATED BIOLOGICAL COMPOSITION PYLA, EVELYN Y 1633 Non-Final OA Feb 17, 2018

Managing Vivex Biologics Group Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month